Posts in: heltzen (2)

CEO Heltzen interviewed by Maxine Hoover at the Beryl Elites’ Investment Conference in New York City
heltzeninvestorpress clippingsvideo
Beryl Elites: What is Artificial Evolution - an interview with CEO HeltzenJanuary 7, 2026
CEO Michael Heltzen at the Beryl Elite's 'AI in Life Sciences' panel
heltzeninvestorpress clippings
Beryl Elites: AI's Billion-dollar Bet on Life Sciences - From Drug Discovery to Patient Impact (panel)December 15, 2025
100× scale-up of NCT production achieved
heltzenpress releaseinvestornutraceuticalsmedicineNCTkorman
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversionDecember 11, 2025
'The Upside' interview: Michael Heltzen & Lou Basenese
heltzeninvestornutraceuticalsmedicinepress clippingsvideoNCTcannabinoids
'The Upside' interview: Michael Heltzen & Lou BaseneseNovember 18, 2025
CEO, Michael Heltzen is interviewed by Jane King
heltzeninvestorpress clippingsvideo
Jane King interviews CEO, Michael Heltzen, in New YorkNovember 12, 2025
CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference
heltzeninvestor
CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment ConferenceOctober 30, 2025
Spartan Capital Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor ConferenceOctober 29, 2025
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor ConferenceOctober 23, 2025
Podcast: 'The Catalyst' interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'The Catalyst' interviews CEO, Michael HeltzenOctober 17, 2025
Inside Biotech podcast interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'Inside Biotech' interviews CEO, Michael HeltzenOctober 2, 2025
Previous page
Page 2 of 3
Next page